Recent review articles about pancreatic cancer (InTextoResearch)




InTextoResearch, scientific information agency

InTextoResearch informs on the most recent review articles about
pancreatic cancer:

Biology and management of pancreatic cancer.
Ghaneh P, Costello E, Neoptolemos JP.
Gut. 2007 Aug;56(8):1134-52.

DNA array/microarrays in oncological research with focus on pancreatic
cancer.
Baron A, Moore PS, Scarpa A.
Adv Clin Path. 2001 Oct;5(4):115-20.

Identifying early symptoms of pancreatic cancer.
Halls BS, Ward-Smith P.
Clin J Oncol Nurs. 2007 Apr;11(2):245-8.

Adjuvant therapy for pancreatic cancer: to treat or not to treat?
Berlin JD.
Oncology (Williston Park). 2007 May;21(6):712-8.

Her signaling in pancreatic cancer.
Burtness B.
Expert Opin Biol Ther. 2007 Jun;7(6):823-9.

Erlotinib: success of a molecularly targeted agent for the treatment
of advanced pancreatic cancer.
Welch SA, Moore MJ.
Future Oncol. 2007 Jun;3(3):247-54.

Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?
Garcea G, Manson MM, Neal CP, Pattenden CJ, Sutton CD, Dennison AR,
Berry DP.
Curr Cancer Drug Targets. 2007 May;7(3):209-15.

Treatment options for hepatobiliary and pancreatic cancer.
Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB, Chari
ST, Martenson JA.
Mayo Clin Proc. 2007 May;82(5):628-37.

Current status of surgery for pancreatic cancer.
Hirata K, Egawa S, Kimura Y, Nobuoka T, Oshima H, Katsuramaki T,
Mizuguchi T, Furuhata T.
Dig Surg. 2007;24(2):137-47.

Targeting signal transduction in pancreatic cancer treatment.
Yeh JJ, Der CJ.
Expert Opin Ther Targets. 2007 May;11(5):673-94.

Spleen-preserving distal pancreatectomy with conservation of the
splenic artery and vein.
Kimura W, Moriya T, Ma J, Kamio Y, Watanabe T, Yano M, Fujimoto H,
Tezuka K, Hirai I, Fuse A.
World J Gastroenterol. 2007 Mar 14;13(10):1493-9.

Precursor lesions of pancreatic cancer: molecular pathology and
clinical implications.
Singh M, Maitra A.
Pancreatology. 2007;7(1):9-19.

Treatment of advanced pancreatic cancer.
Ducreux M, Boige V, Malka D.
Semin Oncol. 2007 Apr;34(2 Suppl 1):S25-30.

Photodynamic therapy for pancreatic cancer.
Fan BG, Andren-Sandberg A.
Pancreas. 2007 May;34(4):385-9.

Review. Molecular background of chemoresistance in pancreatic cancer.
Zalatnai A, Molnar J.
In Vivo. 2007 Mar-Apr;21(2):339-47.

Pancreatic cancer: an update.
Kindler HL.
Curr Oncol Rep. 2007 May;9(3):170-6.

Monoclonal antibody therapies targeting pancreatic ductal
adenocarcinoma.
Engelhardt K, Riley C, Cooke L, Mahadevan D.
Curr Drug Discov Technol. 2006 Dec;3(4):231-43.

Medical treatment of pancreatic cancer.
Lohr JM.
Expert Rev Anticancer Ther. 2007 Apr;7(4):533-44.

Analysis of clinicopathological features and predictors of malignancy
in intraductal papillary mucinous neoplasms of the pancreas.
Fujii T, Ishikawa T, Kanazumi N, Sugimoto H, Nomoto S, Inoue S,
Nagasaka T, Takeda S, Nakao A.
Hepatogastroenterology. 2007 Jan-Feb;54(73):272-7.

Pancreatoscopy: present and future role.
Chen YK.
Curr Gastroenterol Rep. 2007 Apr;9(2):136-43.

Systematic review, including meta-analyses, on the management of
locally advanced pancreatic cancer using radiation/combined modality
therapy.
Sultana A, Tudur Smith C, Cunningham D, Starling N, Tait D,
Neoptolemos JP, Ghaneh P.
Br J Cancer. 2007 Apr 23;96(8):1183-90.

Tumor-stroma interactions in pancreatic ductal adenocarcinoma.
Mahadevan D, Von Hoff DD.
Mol Cancer Ther. 2007 Apr;6(4):1186-97.

The role of protein kinases in pancreatic carcinogenesis.
Ammerpohl O, Kalthoff H.
Clin Chim Acta. 2007 May;381(1):56-62.







(contact at TextoResearch: Marc Lacroix, Baelen, Wallonia, Belgium -
scimedweb@xxxxxxxx)

.



Relevant Pages

  • Talabostat plus =?iso-8859-1?Q?Gemzar=AE?= Shows Potential in Treatment of Advanced Pancreat
    ... Talabostat plus Gemzar® Shows Potential in Treatment of Advanced ... metastatic pancreatic cancer. ... The majority of patients are diagnosed with pancreatic cancer once it has ...
    (sci.med.diseases.cancer)
  • Re: Campaign launched against dietary supplements
    ... I agree that the separation is intentional and detrimental to the patient. ... The doctor should be familiar with both and take the best from both. ... delaying a proven and effective treatment is an excellent idea. ... >>Laetrile if you are ever diagnosed with pancreatic cancer. ...
    (sci.med)
  • Re: Campaign launched against dietary supplements
    ... I agree that the separation is intentional and detrimental to the patient. ... The doctor should be familiar with both and take the best from both. ... delaying a proven and effective treatment is an excellent idea. ... >>Laetrile if you are ever diagnosed with pancreatic cancer. ...
    (sci.med.nutrition)
  • Charlie a friend posted this FYI
    ... Newsgroups: rec.gardens ... OT....Possible Concern to Many...Cancer Treatment in Canada ... chemo for his pancreatic cancer. ...
    (sci.med.cardiology)
  • Telovac trial for pancreatic cancer - UK
    ... GV1001 is a vaccine treatment that is being tested in clinical trials. ... The GV1001 vaccine for pancreatic cancer is new and experimental, ... You have GV1001 as an injection under the skin into the lower part of your ...
    (sci.med.diseases.cancer)

Loading